Prediction of Early Recovery of Liver Function After LDLT in Children: An Ambispective Cohort Study
- Conditions
- Other End-stage Liver Diseases in ChildrenLiver and Biliary Tract Disorders in Duration of Pregnancy
- Registration Number
- NCT06045949
- Lead Sponsor
- Huiwu Xing
- Brief Summary
The investigators included children with living donor liver transplantation (LDLT) from January 1, 2018 to July 31, 2022 as a retrospective cohort, and the group from August 1, 2022 to June 30, 2023 as a prospective cohort. The investigators collected the demographic and clinicopathological data of donors and recipients, and determined the risk factors of early postoperative delayed recovery of hepatic function (DRHF) by univariate and multivariate Logical regression analyses.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 230
- children with the indication of LDLT [cholestatic liver disease (such as BA), metabolic liver disease (such as Wilson's disease and Ornithine transcarbamylase deficiency), acute liver failure (such as drug induced), neoplastic disease (such as hepatoblastoma), vascular disease (such as cavernous transformation of portal vein and congenital absence of portal vein), re-transplantation and others];
- the relatives of the children voluntarily donated part of the liver which met the requirements of LDLT.
- recipients with contraindications of LDLT (such as coagulation dysfunction, acute infection, cardiopulmonary failure);
- failure to complete LDLT due to various reasons (such as death during or within 3 days after operation);
- recipients or donors with incomplete necessary data.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DRHF 30 days after LDLT in children Investigators collected liver function data of children after LDLT. Delayed recovery of hepatic function (DRHF) is characterized by the increase of PT-INR combined with hyperbilirubinemia on or after postoperative day 5.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Children's Hospital of Chongqing Medical University
🇨🇳Chongqing, Chongqing, China